Emile Nuwaysir
Fondateur chez Invenra, Inc.
Profil
Emile F.
Nuwaysir is the founder of Invenra, Inc. He currently holds the position of Chairman at BlueRock Therapeutics Canada ULC since 2021 and Director at Alliance for Regenerative Medicine.
Previously, he served as the Chief Executive Officer & Director at Ensoma, Inc., Principal at Quarles & Brady LLP, Chief Technology Officer at Roche Diagnostics Corp., Vice President-Business Development at NimbleGen Systems, Inc. from 2000 to 2008, and as Principal at The National Institute of Environmental Health Sciences.
Dr. Nuwaysir also held the position of Chief Operating Officer and VP-Research & Development at FUJIFILM Cellular Dynamics, Inc. He obtained a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Delaware.
Postes actifs de Emile Nuwaysir
| Sociétés | Poste | Début |
|---|---|---|
Invenra, Inc.
 Invenra, Inc. Pharmaceuticals: MajorHealth Technology Invenra, Inc. develops technology platform for biological drugs. It is a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies and antibody derivatives. The company was founded by Roland Greene and Emile F. Nuwaysir on July 24, 2014 and is headquartered Madison, WI. | Fondateur | - |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Président | 01/08/2021 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Emile Nuwaysir
| Sociétés | Poste | Fin |
|---|---|---|
NimbleGen Systems, Inc.
 NimbleGen Systems, Inc. BiotechnologyHealth Technology NimbleGen Systems, Inc. Develops micro-arrays used in bio-technology. It also supplies microarray products and services. The company combines photo-deposition chemistry with digital light projection to shorten array fabrication from months to hours. NimbleGen System was founded in 1999 & is headquartered in Madison, WI. | Corporate Officer/Principal | 30/12/2008 |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Directeur Général | - |
Quarles & Brady LLP
 Quarles & Brady LLP Miscellaneous Commercial ServicesCommercial Services Quarles & Brady LLP provides legal services. The firm offers data privacy and security, employee benefits, energy, environment and natural resources, real estate and tax services. The company was founded in 1892 and is headquartered in Milwaukee, WI. | Corporate Officer/Principal | - |
The National Institute of Environmental Health Sciences
 The National Institute of Environmental Health Sciences Miscellaneous Commercial ServicesCommercial Services The National Institute of Environmental Health Sciences provides biomedical research services. The company is headquartered in Raleigh, NC. | Corporate Officer/Principal | - |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Directeur Technique/Scientifique/R&D | - |
Formation de Emile Nuwaysir
| University of Wisconsin | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
NimbleGen Systems, Inc.
NimbleGen Systems, Inc. BiotechnologyHealth Technology NimbleGen Systems, Inc. Develops micro-arrays used in bio-technology. It also supplies microarray products and services. The company combines photo-deposition chemistry with digital light projection to shorten array fabrication from months to hours. NimbleGen System was founded in 1999 & is headquartered in Madison, WI. | Health Technology |
FUJIFILM Cellular Dynamics, Inc.
 FUJIFILM Cellular Dynamics, Inc. BiotechnologyHealth Technology FUJIFILM Cellular Dynamics, Inc. engages in the provision of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. It offers cardiac cells, neural cells. hematopoietic and other, and iPSC, services and reagents. The company was founded by James A. Thomson, Igor Slukvin, Timothy J. Kamp and Craig T. January in 2004 and is headquartered in Madison, WI. | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
The National Institute of Environmental Health Sciences
The National Institute of Environmental Health Sciences Miscellaneous Commercial ServicesCommercial Services The National Institute of Environmental Health Sciences provides biomedical research services. The company is headquartered in Raleigh, NC. | Commercial Services |
Quarles & Brady LLP
Quarles & Brady LLP Miscellaneous Commercial ServicesCommercial Services Quarles & Brady LLP provides legal services. The firm offers data privacy and security, employee benefits, energy, environment and natural resources, real estate and tax services. The company was founded in 1892 and is headquartered in Milwaukee, WI. | Commercial Services |
Invenra, Inc.
Invenra, Inc. Pharmaceuticals: MajorHealth Technology Invenra, Inc. develops technology platform for biological drugs. It is a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies and antibody derivatives. The company was founded by Roland Greene and Emile F. Nuwaysir on July 24, 2014 and is headquartered Madison, WI. | Health Technology |
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Commercial Services |
